Raichur, January 15, 2026
Shilpa Medicare Limited (NSE: SHILPAMED | BSE: 530549) has ceased to be the owner of its Canadian subsidiary following a transfer of equity shares, marking a strategic exit from the overseas unit without any impact on its current financials.
Transaction Details
The company’s wholly owned subsidiary, Koanna Healthcare Canada Inc., allotted 2,84,21,020 equity shares to an individual buyer based in Quebec, Canada. The transaction was executed on January 14, 2026, for a total consideration of CAD 2,000. Following the completion of this share transfer, Koanna Healthcare Canada Inc. is no longer a subsidiary of Shilpa Medicare with effect from the same date.Shilpa Medicare clarified that the investment in the Canadian entity had already been fully provided for in its books. As a result, the transaction does not have any bearing on the company’s current financial position.
Financial Contribution of the Subsidiary
Koanna Healthcare Canada Inc. accounted for a negligible share of the group’s overall operations in the last financial year ended March 31, 2025.| Particulars | Amount (₹ lakh) | Contribution |
|---|---|---|
| Income | 34.33 | 0.03% |
| Net Worth | 46.09 | 0.02% |
Buyer Profile and Other Aspects
The shares were transferred to Steve N. Slilaty, an individual resident of Quebec, Canada. The buyer is not associated with the promoter group or group entities of Shilpa Medicare. The transaction does not involve any related party considerations and was completed outside any scheme of arrangement.About the Company
Shilpa Medicare Limited is a listed pharmaceutical company engaged in the development, manufacturing, and marketing of active pharmaceutical ingredients, formulations, and specialty products. The company has a presence across regulated and semi-regulated markets, with a focus on oncology and complex therapeutics.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.